Aurinia Pharmaceuticals
Price & Volume
Stats
See more52W Range | $6.82-$16.54 |
Market Cap | $1.8B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $283M |
Revenue Growth (YoY) | 28.8% |
Gross Profit (12 Mos) | $250.3M |
Diluted EPS | $0.56 |
News
See moreYahoo Finance • 4 days ago
Here are the major earnings before the open Thursday
Yahoo Finance • 3 months ago
Top SA Quant rated small-cap stocks as Russell 2000 notches a record close
Yahoo Finance • 4 months ago
Top FDA official Tidmarsh resigns after comments on kidney drug, HHS probe
Yahoo Finance • 4 months ago
Aurinia Pharmaceuticals Reaches Analyst Target Price
About
CEO | Mr. Peter S. Greenleaf M.B.A. |
Address | #140, 14315 ? 118 Avenue, Edmonton, AB, Canada, T5L 4S6 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 130 |
